NOx contamination in laboratory ware and effect of countermeasures

被引:43
作者
Ishibashi, T
Himeno, M
Imaizumi, N
Maejima, K
Nakano, S
Uchida, K
Yoshida, J
Nishio, M
机构
[1] Kanazawa Med Univ, Dept Pharmacol, Uchinada, Ishikawa 9200293, Japan
[2] Kanazawa Med Univ, Dept Internal Med, Div Endocrinol, Uchinada, Ishikawa 9200293, Japan
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2000年 / 4卷 / 05期
关键词
nitrite; nitrate; contamination; laboratory wares;
D O I
10.1006/niox.2000.0302
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Contamination of various types of laboratory wares with NOx (NO2- and NO3-) was assessed systematically and the effect of extensive washing as a countermeasure was evaluated. Mean NOx contamination arising from a model procedure for NOx determination in plasma was 0.93 muM (range, 0.35-1.49 muM). The major source of contamination included conical tubes (54.8%) and pipette tips used for transfer of solution (12.3-16.3%). Except for soft glassware, most NOx contamination could be washed out by pure water. Although NOx contamination in respective laboratory wares could be reduced below detection levels by extensive washing, summation of the contamination through the model procedure could not be completely abolished (but the effect of washing persisted at least 10 days), Heavy contamination was noted in glassware (especially soft glass) and ultrafiltration units, which was difficult to remove. Several types of vacuum blood sampling tubes contained various levels of NOx. Our results indicated that a small but significant amount of contamination remained in laboratory ware even after extensive washing, and that it is advisable to avoid the use of glassware (soft glass), ultrafiltration units, and vacuum blood sampling tubes during the processing of clinical sampling for the measurement of NOx. (C) 2000 Academic Press.
引用
收藏
页码:516 / 525
页数:10
相关论文
共 27 条
[1]
Åhrén C, 1999, SCAND J INFECT DIS, V31, P405
[2]
Production of oxidative products of nitric oxide in infarcted human heart [J].
Akiyama, K ;
Kimura, A ;
Suzuki, H ;
Takeyama, Y ;
Gluckman, TL ;
Terhakopian, A ;
Katagiri, T ;
Suh, KY ;
Roseto, J ;
Bing, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (02) :373-379
[3]
MEASUREMENT OF NITRIC-OXIDE IN BIOLOGICAL MODELS [J].
ARCHER, S .
FASEB JOURNAL, 1993, 7 (02) :349-360
[4]
Cyclic GMP elevation by 5-hydroxytryptamine is due to nitric oxide derived from endogenous nitrosothiol in NG108-15 cells [J].
Arima, T ;
Ohshima, Y ;
Mizuno, T ;
Kitamura, Y ;
Segawa, T ;
Nomura, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 227 (02) :473-478
[5]
Butler AR, 1997, ANAL BIOCHEM, V249, P1
[6]
CLINICAL BIOLOGY OF NITRIC-OXIDE [J].
DAVIES, MG ;
FULTON, GJ ;
HAGEN, PO .
BRITISH JOURNAL OF SURGERY, 1995, 82 (12) :1598-1610
[7]
Nitrite and nitrate analyses: A clinical biochemistry perspective [J].
Ellis, G ;
Adatia, I ;
Yazdanpanah, M ;
Makela, SK .
CLINICAL BIOCHEMISTRY, 1998, 31 (04) :195-220
[8]
NITRIC-OXIDE IN BIOLOGICAL-FLUIDS - ANALYSIS OF NITRITE AND NITRATE BY HIGH-PERFORMANCE ION CHROMATOGRAPHY [J].
EVERETT, SA ;
DENNIS, MF ;
TOZER, GM ;
PRISE, VE ;
WARDMAN, P ;
STRATFORD, MRL .
JOURNAL OF CHROMATOGRAPHY A, 1995, 706 (1-2) :437-442
[9]
Evaluation of NOx in the cardiovascular system: Relationship to NO-related compounds in vivo [J].
Ishibashi, T ;
Yoshida, J ;
Nishio, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1999, 81 (04) :317-323
[10]
Ishibashi T, 1999, LIFE SCI, V66, P173